Norman L. Sussman
2021
In 2021, Norman L. Sussman earned a total compensation of $723.5K as Chief Medical Officer at DURECT, a 73% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $128,815 |
|---|---|
| Option Awards | $153,160 |
| Salary | $400,970 |
| Other | $40,539 |
| Total | $723,484 |
Sussman received $401K in salary, accounting for 55% of the total pay in 2021.
Sussman also received $128.8K in non-equity incentive plan, $153.2K in option awards and $40.5K in other compensation.
Rankings
In 2021, Norman L. Sussman's compensation ranked 9,801st out of 12,415 executives tracked by ExecPay. In other words, Sussman earned more than 21.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,801 out of 12,415 | 21st |
Division Manufacturing | 4,341 out of 5,505 | 21st |
Major group Chemicals And Allied Products | 1,931 out of 2,375 | 19th |
Industry group Drugs | 1,715 out of 2,096 | 18th |
Industry Pharmaceutical Preparations | 1,275 out of 1,546 | 18th |
Source: SEC filing on April 25, 2022.
Sussman's colleagues
We found three more compensation records of executives who worked with Norman L. Sussman at DURECT in 2021.